CLINICAL_TRIALS trial_result · 2021-05-25

Clinical Trial Update: Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients [Phase 2, Phase 3]

Clinical trial update for an intravenous iron supplement in heart transplant recipients; study phases 2 and 3 have completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Oslo University Hospital | Conditions: Heart Transplant Recipients | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-05-25